Blog

Endoscopy allows direct visual examination of the digestive tract lining and enables biopsy collection, making it ideal for diagnosing ulcers, inflammation, and suspected cancers. CT scans are better for evaluating surrounding abdominal organs, structural anatomy, and emergencies such as perforations, abscesses, or deeper masses that extend beyond the digestive tract. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “CT and endoscopy answer different questions and the mistake clinicians make is treating them as interchangeable when they are not, ordering CT first for a mucosal problem means the diagnosis gets delayed by weeks while the endoscopy that would have found it same day gets ordered second.” What Does Endoscopy Do Better Than CT? Mucosal disease. Anything at the lining level of the GI tract. CT does not see this and was never designed to. Early Mucosal Cancers: Flat mucosal lesions in the stomach, oesophagus, and colon invisible on CT found routinely through endoscopy, removed in same session through EMR or ESD without surgery, outcome completely changes because endoscopy found it at mucosal stage before CT would have shown anything at all. Ulcers and Active Bleeding: CT cannot confirm active GI bleeding source with the accuracy endoscopy provides, ulcers identified and treated through injection, clipping, or coagulation in same session, patient avoids surgery entirely in most cases. H. Pylori and Mucosal Biopsy: CT shows nothing for gastritis and H. pylori infection, endoscopy takes biopsy from affected tissue directly, confirms diagnosis in days, treatment starts with actual evidence rather than clinical assumption. Polyp Detection and Removal: Colonoscopy finds and removes colorectal polyps before they progress to cancer in same session, CT colonography misses flat polyps under 6mm routinely and cannot remove anything it does find regardless. When the clinical question is what’s happening at the lining level, endoscopy answers it and CT does not. Specialist in endoscopy treatment gets to the right answer without sending patient through unnecessary investigations first. What Does CT Do Better Than Endoscopy? Anything involving organ size, masses, metastasis, lymph nodes, or structures endoscopy cannot reach. Distant Metastasis: Liver metastasis, lung spread, peritoneal disease, enlarged distant lymph nodes  CT maps all of this in one scan, endoscopy sees none of it because the camera stays inside the GI tract lumen. Organ Assessment Beyond GI Tract: Pancreatic size and obvious masses, adrenal glands, kidneys, retroperitoneal structures CT covers the whole abdomen in one go, endoscopy is organ-specific and reaches only what the scope physically enters. Bowel Obstruction and Perforation: Acute presentations needing fast anatomical overview, obstruction location, free air from perforation, CT is the right first investigation here, endoscopy carries risk in acute obstruction and is not the appropriate starting point. Pre-surgical Staging Overview: Broad anatomical staging before surgery needs CT for the full picture, though EUS adds T and N staging accuracy for oesophageal, gastric, and pancreatic cancers that CT alone consistently gets wrong. For staging, anatomy, and distant spread CT is right. For mucosal disease, biopsy, and treatment endoscopy wins every time. Read more on advanced GI procedures without open surgery to see what endoscopy actually delivers beyond just diagnosis. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has over 30 years of diagnostic and therapeutic endoscopy experience including EUS since 1998, and has spent enough time reading CT reports followed by endoscopy findings to know exactly where CT stops being reliable and endoscopy needs to take over. Trained physicians from 35 countries in making exactly this distinction at Fortis Hospital Mulund. Patients come in having had three CT scans and no endoscopy. Most leave with a finding the CT never showed. Same day. Right investigation. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions When should endoscopy be chosen over CT scan for GI problems? Endoscopy is preferred for mucosal disease, ulcers, early cancers, bleeding, polyps, and any condition requiring biopsy or direct treatment. Can CT scan replace colonoscopy for colorectal cancer screening? No. CT colonography misses flat polyps and cannot remove lesions it finds, making colonoscopy the gold standard for colorectal screening. Is EUS better than CT for pancreatic cancer staging? Yes. EUS provides superior T and N staging accuracy for pancreatic cancer and finds sub-2cm lesions CT consistently misses. Can both endoscopy and CT be done together for GI diagnosis? Yes. Many cases need both, CT for overall staging and anatomy, endoscopy for mucosal assessment and tissue confirmation through biopsy. Reference links- Endoscopy vs Imaging in GI Diagnosis — American Society for Gastrointestinal Endoscopy GI Diagnostic Tools and Guidelines — World Gastroenterology Organisation

Pancreatitis is inflammation of the pancreas, acute or chronic, caused by gallstones, alcohol, or other triggers, treatable and often reversible. Pancreatic cancer is malignant tumour growth in pancreatic tissue, progressive, life-threatening if not caught early. Both cause upper abdominal pain, nausea, and weight loss which is why they get confused constantly. Key difference: pancreatitis responds to treatment and stabilises, pancreatic cancer progresses regardless and needs urgent investigation. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “Pancreatitis and pancreatic cancer overlap in symptoms enough that patients get treated for one while actually having the other, and that diagnostic gap costs time nobody can afford when cancer is the actual problem.” How Are Pancreatitis and Pancreatic Cancer Different? Same organ. Completely different disease processes. And the consequences of mixing them up are not small. What Causes Each: Pancreatitis has identifiable triggers in most cases, gallstones, alcohol, certain medications, high triglycerides, pancreatic cancer often shows up with no obvious cause the patient or their doctor thought to question. Pain behaves differently: Pancreatitis pain is episodic, severe, radiates to back, improves with fasting, pancreatic cancer pain is relentless and progressive, doesn’t improve with diet changes or treatment, just keeps getting worse until someone investigates properly. Amylase and lipase spike dramatically in acute pancreatitis. In pancreatic cancer both are often completely normal. CA 19-9 elevated in cancer but also in benign conditions. Ordering only the wrong blood panel and stopping there is how cancer gets missed for months in patients who look like they have pancreatitis. Imaging: CT shows swelling and fluid in pancreatitis, calcifications in chronic cases, pancreatic cancer shows mass but sub-2cm tumours are missed on CT routinely, need EUS to actually find them. Getting the right diagnosis from the start changes everything that follows. Specialist in pancreatitis treatment investigates both possibilities properly rather than defaulting to the easier diagnosis. What Does Endoscopy Treat in Digestive Diseases? These patterns keep getting missed. Worth knowing what to flag. Idiopathic: No identifiable trigger for pancreatitis, no alcohol, no gallstones, no medication, symptoms still present. That combination needs cancer ruled out before pancreatitis gets managed as standalone condition and the real problem stays hidden another six months. Weight loss that doesn’t stop: Pancreatitis weight loss stabilises once inflammation treated. Progressive weight loss continuing despite treatment is not a pancreatitis pattern. Needs EUS. New-Onset DiabetesNew diabetes appearing at same time as upper GI symptoms in patient over 50 with no metabolic risk factors. Tumour disrupting insulin-producing tissue. Gets filed under endocrine disease. Pancreas never checked. First acute episode after 50 with no cause: Needs EUS to rule out cancer before pancreatitis gets treated as standalone. Not after three months of management. Before. Pancreatitis that doesn’t behave like pancreatitis needs a second look before more treatment goes in the wrong direction. Read more on advanced GI procedures without open surgery to understand what proper investigation looks like. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has over 30 years of experience distinguishing pancreatitis from pancreatic cancer in cases where standard imaging leaves uncertainty, with EUS expertise since 1998 that helps detect malignancies hidden behind inflammatory disease even when CT scans and blood tests appear inconclusive. He has trained physicians from 35 countries in this specialised diagnostic approach at Fortis Hospital Mulund. Patients often arrive after being treated for pancreatitis for months while an underlying condition remains undetected, and identifying that missed diagnosis is a key part of his clinical expertise. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions Can pancreatitis turn into pancreatic cancer? Chronic pancreatitis increases pancreatic cancer risk over time but most pancreatitis cases do not progress to cancer. How do doctors tell pancreatitis apart from pancreatic cancer? EUS, CT, MRI, blood tests including CA 19-9, amylase, and lipase, and clinical pattern together differentiate the two conditions accurately. Is pancreatic cancer always painful? Not always early on. Pain becomes more consistent as disease progresses and tumour compresses surrounding nerves and structures. Can pancreatitis and pancreatic cancer occur together?Yes, chronic pancreatitis can coexist with pancreatic cancer and the pancreatitis can actually mask the cancer making diagnosis harder. Can pancreatitis and pancreatic cancer occur together?Yes, chronic pancreatitis can coexist with pancreatic cancer and the pancreatitis can actually mask the cancer making diagnosis harder.Can pancreatitis and pancreatic cancer occur together?Yes, chronic pancreatitis can coexist with pancreatic cancer and the pancreatitis can actually mask the cancer making diagnosis harder. Can pancreatitis and pancreatic cancer occur together? Yes, chronic pancreatitis can coexist with pancreatic cancer and the pancreatitis can actually mask the cancer making diagnosis harder. Reference links- Pancreatitis and Pancreatic Cancer Differentiation — American College of Gastroenterology Pancreatic Disease Diagnosis Guidelines — World Gastroenterology Organisation

Most people have dealt with that uncomfortable, heavy feeling after a big meal at some point. But what happens when it’s not just once in a while — what if it happens every single time you eat, regardless of what’s on your plate? That’s when indigestion stops being a passing inconvenience and starts becoming a real problem worth investigating. Medically, this condition is referred to as dyspepsia. It’s not a disease on its own, but rather a collection of symptoms that point toward something going wrong in the digestive process. For some people, it’s been going on for years, and they’ve simply learned to live with the discomfort — which, unfortunately, is not the right approach. Dr. Vipulroy Rathod, a globally recognized gastroenterologist in Mumbai, India, puts it plainly:  “When patients visit me and tell they have indigestion after every meal, my first advice to them is you must not accept this as normal. Persistent dyspepsia is your gut’s way of communicating that something is not functioning properly. Most of the time, after we figure out the root cause, treatment is quite easy. However, if it remains untreated for a long time, the situation can become more and more complicated.” Dr. Rathod has been a source of help to patients from India and around the world who suffer from chronic digestive problems by helping them get rid of these problems permanently. His method is not only about relieving symptoms rather, it is about finding out the reason behind them. What Exactly Is Indigestion and Why Does It Keep Happening? The stomach matters a lot in digestion. When you eat, it starts working right away, producing acid, contracting muscles to break down food. These processes happen without you thinking about them. But sometimes, the stomach can’t handle what you’re eating. You feel a burning in your chest or notice food just sitting there without moving through. If this happens after every meal, something’s wrong. It’s not a one-off issue There’s a pattern. Something consistently messes with digestion. The problem isn’t temporary. You need to figure out what’s causing it – before symptoms get worse. What Could Be Causing It? Common Reasons Behind Post-Meal Indigestion There’s rarely one single explanation. Several conditions — some quite common, others less so — can lead to indigestion that shows up meal after meal: Acid Reflux or GERD One of the most frequent culprits. Stomach acid pushes back up into the esophagus, creating burning and discomfort, especially after larger meals or when lying down too soon after eating. Gastritis The stomach lining becomes inflamed, often due to an H. pylori bacterial infection, long-term use of painkillers like ibuprofen, or excessive alcohol consumption. Peptic Ulcers Open sores in the stomach or upper small intestine that get aggravated when stomach acid comes into contact with food. Functional Dyspepsia A surprisingly common condition where there's no visible structural problem, yet the digestive system consistently underperforms. It's often linked to gut-brain communication issues. Gastroparesis The stomach empties too slowly, so food lingers much longer than it should, leading to bloating, nausea, and fullness that lasts for hours. Hiatal Hernia Part of the stomach slides up through the diaphragm into the chest cavity, which disrupts normal digestive mechanics and worsens reflux. Food Intolerances Lactose, gluten, or other food sensitivities can create consistent post-meal discomfort if the offending food is a regular part of your diet. Eating Habits Eating too fast, skipping meals and then overeating, or regularly reaching for greasy or highly spiced food puts ongoing strain on the digestive system. Understanding which of these applies to you is what drives the treatment decision. Persistent indigestion after meals deserves proper attention. Schedule a consultation with Dr. Vipulroy Rathod for an in-depth evaluation and a treatment plan built around your specific needs. Book Appointment Symptoms That Tell You It’s More Than Just Overeating There’s a difference between feeling a bit full after a heavy meal and experiencing symptoms that follow you after every sitting, no matter what or how much you’ve eaten. Here’s what to pay attention to: Burning or aching in the upper abdomen — not just heartburn, but a deeper discomfort that starts during or shortly after eating. Bloating that doesn’t go away quickly — a sense of tightness or pressure in the stomach that can last for hours. Nausea — sometimes mild, sometimes strong enough to put you off food entirely. Frequent belching or gas — the body’s attempt to release built-up pressure in the stomach. Feeling full after just a few bites — known as early satiety, this is particularly associated with gastroparesis and functional dyspepsia. Regurgitation — food or acid coming back up, sometimes with a sour or bitter taste. Heartburn — a burning feeling that travels from the stomach up into the chest or throat. Dr. Rathod advises that if any of these symptoms are accompanied by significant weight loss, difficulty swallowing, blood in the stool, or persistent vomiting, medical evaluation should not be delayed. These could point to something more serious that requires urgent attention. Treatment: What Actually Helps With Chronic Indigestion? The good news is that most causes of chronic indigestion are very treatable. The approach depends on what’s been found: Acid-reducing medications such as proton pump inhibitors (PPIs) or H2 blockers are commonly prescribed for GERD, gastritis, and ulcer-related indigestion. Antibiotics combined with acid suppressants are used specifically to clear pylori infections. Prokinetics — medications that help the stomach contract and empty more efficiently — are useful when gastroparesis or slow digestion is the issue. Dietary adjustments are almost always part of the plan. Reducing fatty foods, spicy dishes, caffeine, and carbonated drinks removes a lot of the strain on an already irritated gut. Stress management plays a bigger role than most people expect. The gut and brain are deeply connected, and chronic stress is a genuine driver of functional digestive issues. Endoscopic treatment may be required in some cases — for instance, when a hiatal hernia needs correction or when ulcers

Endoscopy is a key part of modern gastroenterology, allowing doctors to directly examine the digestive tract using a flexible camera. It helps diagnose, stage, and treat conditions such as ulcers, inflammation, cancer, bleeding, and celiac disease, making it essential for both accurate diagnosis and minimally invasive treatment. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Endoscopy changed digestive disease management completely because it moved diagnosis and treatment from assumption based on external imaging to direct visualisation and intervention inside the organ itself, and that difference in accuracy is not marginal.” What Does Endoscopy Diagnose in Digestive Diseases? Conditions missed entirely through scans get picked up through endoscopy. Not occasionally. Regularly. That’s the point. Early GI Cancers, Found Before Symptoms: Upper endoscopy and colonoscopy find mucosal cancers and precancerous changes before patients feel anything wrong, and superficial lesions found this way can be removed in the same session without surgery through EMR or ESD that option only exists because someone looked early enough. Ulcers and Gastritis: Direct visualisation of stomach lining finds ulcers, erosions, mucosal damage that CT misses routinely, biopsy confirms H. pylori or rules malignancy out on the spot. IBD Mucosal Picture: Colonoscopy with biopsy gives actual mucosal activity, extent, and treatment response for Crohn’s and ulcerative colitis, external imaging gives an approximation, this gives the real picture. EUS for Pancreas and Bile Duct: Pancreatic lesions, ductal changes, bile duct stones, nodal involvement all from inside the stomach wall at proximity no external scan comes close to for these structures. Right tool for right clinical picture. Specialist in endoscopy treatment knows which one applies without sending patient through three investigations first. What Does Endoscopy Treat in Digestive Diseases? Not just diagnosis. Endoscopy treats. Same session, no surgery, patient goes home. Polyps Out Before They Turn: Colonoscopic polypectomy removes precancerous colorectal polyps before cancer develops, no incision, no recovery ward, no surgical risk, patient out same day this is standard practice and it consistently works. Bleeding Stopped on the Spot: Active GI bleeding from ulcers, varices, vascular lesions controlled through endoscopic clipping, injection, or argon plasma coagulation in same session as diagnosis, most cases no general anaesthetic needed. ERCP, No Surgery for Bile Duct Stones: Stones in common bile duct causing jaundice and pancreatitis removed endoscopically, stents placed for strictures same procedure, recovery days not weeks, open surgery avoided completely. Tumour Resection, No Knife: Early mucosal stomach and oesophageal cancers removed through ESD in one piece, margins confirmed histologically, patient avoids major surgery  works only when cancer found early, which is the whole argument for surveillance. Endoscopy is where digestive disease management actually happens for patients who get properly investigated. Read more on therapeutic endoscopy to understand what’s possible without surgery. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has performed tens of thousands of diagnostic and therapeutic endoscopic procedures over 30 years, with specific mastery in EUS, ESD, ERCP, and third space endoscopy that most gastroenterologists in India refer out rather than handle themselves. Trained physicians from 35 countries in advanced endoscopic techniques at Fortis Hospital Mulund. Patients who need endoscopy done properly the first time, not repeated after an incomplete attempt elsewhere, come here. Diagnosis confirmed, treatment done, same session. That’s the standard here. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions What conditions does upper GI endoscopy diagnose? Upper endoscopy diagnoses ulcers, gastritis, GERD, oesophageal cancer, stomach cancer, and H. pylori related disease among others. Is endoscopy painful? Endoscopy is performed under sedation and most patients experience minimal discomfort during and after the procedure. Can endoscopy treat cancer without surgery? Yes, early mucosal cancers of the stomach and oesophagus can be completely removed through endoscopic submucosal dissection without open surgery. How long does a diagnostic endoscopy take? Most diagnostic upper endoscopies take 15 to 30 minutes and colonoscopies 30 to 45 minutes under sedation. Reference links- Role of Endoscopy in GI Disease — American Society for Gastrointestinal Endoscopy Endoscopy Guidelines and Indications — World Gastroenterology Organisation

Early detection of digestive cancer is critical because stage at diagnosis directly determines survival, treatment options, and quality of life. Colorectal cancer caught at Stage 1 has over 90% 5-year survival while Stage 4 drops below 15%. Pancreatic cancer found early enough for surgery gives 20 to 30% 5-year survival versus under 5% when found late. The biology doesn’t change. What changes is what’s still possible when you find it. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “Early detection isn’t just about finding cancer sooner, it is about finding it while something can still be done about it, and for most digestive cancers that window is narrower than patients and even some doctors realise.” How Does Early Detection Change Digestive Cancer Outcomes? Stage at diagnosis determines more than any treatment advance in recent years. Everything else is secondary to what stage the patient walks in at. Surgery Stays Possible: Early GI cancers are resectable and some are removable through endoscopic resection without open surgery at all, once disease reaches Stage 3 or 4 surgery comes off the table in most cases and gets replaced with systemic treatment that controls rather than cures. Endoscopic Resection, No Surgery Needed: Superficial stomach and oesophageal cancers at mucosal level can be taken out entirely through EMR or ESD without cutting the patient open, that option disappears once tumour has grown past the submucosa and nobody gets it back. Less Aggressive Treatment: Early stage cancers need less chemotherapy or none at all in some cases, late stage disease means prolonged multi-agent regimens with significant side effect burden for however long treatment runs. Survival Gap Is Enormous: Stage 1 colorectal above 90%, Stage 4 under 15%, Stage 1 gastric above 95% with endoscopic resection, Stage 4 under 10%  not marginal differences, completely different clinical pictures that share only the same name. Finding it early changes everything that follows. Specialist in GI cancer treatment builds treatment plans around early findings rather than managing advanced disease after the window has already closed. What Gets in the Way of Early Detection in India? Several things compound each other. Most are fixable once patients understand them. Symptoms Feel Ordinary: Acidity, bloating, mild abdominal discomfort, irregular bowel movements these are early cancer symptoms that get managed with antacids for months while disease progresses quietly in the background and nobody connects the dots. Normal CT Stops Investigation Dead: CT misses early pancreatic lesions, small mucosal stomach cancers, sub-2cm oesophageal tumours routinely, normal CT report gives false reassurance, investigation stops, EUS would have found something in the same patient on the same day. No Routine Screening Happening: Colonoscopy after 45, upper GI endoscopy for high-risk groups, EUS surveillance for pancreatic cancer family history none of this happens routinely in India outside specialist centres so cancers that should be found early aren’t. Referral Chain Takes Too Long: GP to gastroenterologist referral takes time, patients cycle through multiple consultations before anyone orders the investigation that actually finds something, every month of delay in pancreatic adenocarcinoma changes what stage they arrive at for treatment. Early detection is possible with the right approach and the right investigation. Read more on EUS guided drainage success rates to understand what advanced endoscopic intervention delivers when disease is caught in time. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod 30 years gastroenterology, EUS since 1998, trained physicians from 35 countries. Finds early GI cancers at Fortis Hospital Mulund that CT-dependent workups missed completely, has been doing this long enough to know exactly where standard investigations stop being reliable. Patients come in with months of managed symptoms and clean scan reports. Most leave with a real finding. That gap is the whole point of coming here. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions At what age should digestive cancer screening start in India? Colonoscopy screening should start at 45 for average risk individuals and earlier for those with family history of GI cancers. Can digestive cancer be completely cured if caught early? Yes, Stage 1 colorectal and stomach cancers have cure rates above 90% with surgery or endoscopic resection when caught at mucosal level. How is early digestive cancer detected without obvious symptoms? EUS, colonoscopy, and upper endoscopy find early cancers in high-risk patients before symptoms develop through active surveillance. What is the most important test for early digestive cancer detection? EUS is the most sensitive tool for early pancreatic and upper GI cancers while colonoscopy remains gold standard for colorectal cancer. Reference links- Early GI Cancer Detection Guidelines — American College of Gastroenterology Digestive Cancer Screening and Survival — World Gastroenterology Organisation

Survival rates for digestive cancers in India vary significantly by cancer type and stage at diagnosis. Colorectal cancer caught at Stage 1 has a 5-year survival rate above 90%, dropping to under 15% at Stage 4. Pancreatic cancer overall 5-year survival sits around 8 to 10% because most cases are found late. Stomach and oesophageal cancers follow a similar pattern. Stage at detection is the single biggest factor. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “Survival statistics for digestive cancers in India look poor largely because most patients arrive at advanced stage, and that is not a reflection of how treatable these cancers are when found early, it is a reflection of how late investigation happens.” What Are the Survival Rates for Different Digestive Cancers? Each cancer type has its own survival profile. Some are very treatable early. Some are difficult even at early stage. Worth knowing the difference. Colorectal Cancer, Best Survival Profile: Stage 1 colorectal cancer has 5-year survival above 90% with surgery, Stage 2 around 70 to 80%, Stage 3 drops to 40 to 60% depending on nodal involvement, Stage 4 under 15%  the gap between early and late detection here is bigger than almost any other GI cancer. Stomach Cancer, Dramatically Stage Dependent: Early gastric cancer caught at mucosal level has 5-year survival above 95% with endoscopic resection, but most Indian patients present at Stage 3 or 4 where survival drops to 20 to 30%, and that gap exists because early stomach cancer produces no symptoms that feel alarming. Pancreatic Cancer, Hardest Numbers: Overall 5-year survival around 8 to 10% in India, surgical resection at Stage 1 pushes that to 20 to 30%, but less than 20% of pancreatic cancer cases in India are caught at resectable stage because the investigation that finds it early simply isn’t being done at the right time. Oesophageal Cancer, Tobacco and Late Presentation: 5-year survival for localised oesophageal cancer is around 40 to 50%, for regional spread drops to 20 to 25%, for distant metastasis under 5% and most Indian patients present with dysphagia that’s already been progressing for months before anyone scopes them. Stage at diagnosis changes survival more than any treatment advance in the last decade. Specialist in GI cancer treatment catches cases early enough for those better survival numbers to actually apply. What Actually Determines Survival in Digestive Cancers? Not just stage. Several factors compound each other and most patients aren’t told about all of them. Stage at Diagnosis, Dominates Everything: Already said it but it needs repeating because patients focus on treatment options when the more important variable is already fixed at the point of diagnosis, finding it early is worth more than any specific treatment protocol. Investigation Accuracy Matters: Wrong staging means wrong treatment and wrong treatment wastes time the patient doesn’t have, EUS-based staging for pancreatic, oesophageal, and gastric cancers consistently outperforms CT-only staging and that accuracy difference has direct survival implications. Time Between Suspicion and Diagnosis: Indian data consistently shows months of delay between first symptom and confirmed diagnosis, every month of delay in GI cancers with fast doubling times like pancreatic cancer meaningfully changes what stage the patient arrives at for treatment. Access to the Right Specialist: General physician to gastroenterologist to oncologist referral chain takes time in India and patients with vague symptoms often cycle through multiple consultations before anyone orders the investigation that actually finds something. Survival statistics look discouraging until you look at what they’re measuring. Read more on what EUS can diagnose to understand how the right investigation changes the starting point. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod 30 years gastroenterology, EUS since 1998, trained physicians from 35 countries. Sees GI cancer cases at every stage at Fortis Hospital Mulund and has been doing this long enough to know that the patients who do well are almost always the ones who got properly investigated before the disease declared itself loudly. Months of normal reports. Vague symptoms nobody pinned down. Most patients with that history leave here with an actual finding. Not a referral. A diagnosis. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions What is the survival rate for pancreatic cancer in India? Overall 5-year survival is around 8 to 10% but rises to 20 to 30% when caught at a surgically resectable early stage. Which digestive cancer has the best survival rate in India? Colorectal cancer caught at Stage 1 has a 5-year survival above 90% making it one of the most survivable GI cancers when detected early. Does early detection really improve digestive cancer survival? Yes, significantly. Stage 1 and Stage 4 survival rates for most digestive cancers differ by 60 to 80 percentage points. Why are digestive cancer survival rates lower in India than in Western countries? Later stage at diagnosis due to delayed investigation and limited routine screening programmes accounts for most of the survival gap. Reference links- GI Cancer Survival Data India — Indian Council of Medical Research Digestive Cancer Outcomes and Staging — World Gastroenterology Organisation

Tests used to detect pancreatic disease early include endoscopic ultrasound (EUS), CT scan, MRI with MRCP, blood tests including CA 19-9 and amylase, and endoscopic retrograde cholangiopancreatography (ERCP). EUS is the most sensitive tool for early pancreatic lesions, finding tumours under 2cm that CT and MRI regularly miss. Blood tests alone are not reliable for early detection. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Most pancreatic disease gets found late because patients and doctors rely on CT scans that look normal while something small but significant is already present, EUS exists specifically to close that gap and it does it consistently.” Which Tests Are Used to Detect Pancreatic Disease Early? Not all tests detect pancreatic disease equally. The pancreas lies deep, and standard investigations often reach their limits quickly. EUS, the Most Accurate Tool Available: Probe sits millimetres from pancreatic surface inside the stomach wall, images from that proximity find sub-2cm lesions, ductal changes, cysts, and early tumours that external scans miss routinely and that’s not an occasional occurrence, it’s the norm. CT Scan, Good for Obvious Disease: CT is fast, widely available, and picks up larger masses and distant metastasis well, but misses early pancreatic cancer consistently because the organ’s retroperitoneal location means too much tissue between the scanner and the target. MRI with MRCP: Better than CT for ductal anatomy and cystic lesions, MRCP maps the pancreatic duct without contrast injection and is particularly useful for patients with suspected chronic pancreatitis or intraductal papillary mucinous neoplasms where duct changes matter. Blood Tests, Limited but Useful: CA 19-9 elevated in pancreatic cancer but also in benign conditions like pancreatitis and bile duct obstruction, amylase and lipase spike during acute pancreatitis episodes, none of these replace imaging but they help build the clinical picture when used alongside it. Right investigation from the start changes what gets found. Specialists in endoscopic ultrasound don’t just order tests, they know exactly which one applies to the specific clinical picture in front of them. When Should You Get Tested for Pancreatic Disease? Most people wait for a major symptom, but by then the window for early detection has often already passed Family History, Start Now: One first-degree relative with pancreatic cancer means active EUS surveillance should already be happening, not being considered for the future, because the precancerous changes EUS finds are exactly the ones that matter before they become cancer. Chronic Pancreatitis Patients: Repeated pancreatic inflammation carries real malignant transformation risk over time and patients with established chronic pancreatitis need periodic EUS monitoring not just symptom management between flares. New Onset Diabetes After 50: Already covered under risk factors but worth repeating here because it’s the most commonly missed clinical trigger for pancreatic investigation, gets filed as endocrine disease, managed with medication, pancreas never checked. Vague Symptoms, Normal CT: Upper abdominal discomfort, unexplained weight loss, back pain, nausea that doesn’t explain itself and a CT that shows nothing — that combination is exactly the clinical picture where EUS finds things and CT didn’t, not occasionally but regularly. Don’t wait for symptoms to get obvious before investigating properly. Read more on POEM procedure to understand what advanced endoscopic intervention looks like when early detection leads to action. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has been doing EUS since 1998. Over 30 years in gastroenterology. Trained physicians from 35 countries. At Fortis Hospital Mulund he handles the full pancreatic disease spectrum from initial investigation through complex intervention and has seen enough normal CT reports with abnormal EUS findings to know exactly why the right test matters. Patients come in after months of reassurance based on one scan. Most leave with a finding nobody else looked for. That’s the difference. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions Can EUS detect pancreatic cancer before symptoms appear? Yes, EUS regularly finds early pancreatic lesions and ductal changes in high-risk patients before any symptoms develop. Is CA 19-9 reliable for early pancreatic cancer detection? No, CA 19-9 is elevated in benign conditions too and is not reliable enough for standalone early detection without imaging. How often should high-risk patients get EUS for pancreatic surveillance? Most guidelines recommend annual EUS surveillance for high-risk patients including those with BRCA2 mutations or strong family history. Does MRCP replace EUS for pancreatic diagnosis? No, MRCP maps ductal anatomy well but EUS provides superior sensitivity for small lesions and allows biopsy in the same session.   Reference links- Pancreatic Disease Diagnosis and Surveillance — American College of Gastroenterology Early Pancreatic Cancer Detection Guidelines — World Gastroenterology Organisation

Cancer staging in digestive cancers uses the TNM system to classify how far cancer has spread: T for tumour depth into the organ wall, N for lymph node involvement, M for distant metastasis. Stage 1 is localised, Stage 4 means spread to distant organs like liver or lungs. Staging directly decides whether surgery is possible, what treatment sequence applies, and what realistic outcomes look like for each patient. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “Most patients arrive with a stage assigned from a CT report done in a hurry and that stage is frequently wrong EUS changes T and N staging in a significant proportion of GI cancer cases and the treatment changes with it.” Why Does Accurate Staging Change Everything? Wrong stage means wrong treatment. Simple as that. Here’s where staging errors actually happen. CT Misses Small Nodal Deposits: Standard CT regularly misses lymph node involvement in early GI cancers because nodes need to be visibly enlarged to show up, and small deposits in normal-sized nodes are exactly what EUS finds and CT doesn’t. T Stage Gets Underestimated on CT: Tumour depth into the organ wall is consistently harder to assess from outside the body, and understaging the T component means patients get offered endoscopic resection for a tumour that has already gone deeper than the scan suggested. Restaging After Treatment Gets Skipped: After chemotherapy or radiation the tumour needs restaging before surgery is reconsidered, this step gets skipped more often than it should and patients go into surgery without anyone confirming what the treatment actually did to the tumour. Stage 4 Gets Missed Early: Small liver metastases and peritoneal deposits are regularly absent on initial staging scans and show up later, which is why high-risk cases need more thorough staging workup not just a single CT before treatment decisions get made. Staging isn’t a one-time checkbox. Read more on POEM procedure to understand how advanced endoscopic procedures work alongside cancer staging in GI management. How Does Diabetes Increase Pancreatic Disease Risk? Alcohol is a Group 1 carcinogen. No safe level for cancer risk has been established and the GI tract takes the most direct hit of any organ system. Liver Cancer Through Cirrhosis: Chronic alcohol use causes cirrhosis and cirrhosis is the strongest single risk factor for hepatocellular carcinoma, cirrhotic patients carry a 1 to 5% annual liver cancer risk regardless of whether they’ve stopped drinking by that point. Colorectal Cancer, Even Moderate Drinking: Risk rises linearly with consumption and even 1 to 2 drinks per day is associated with measurably increased colorectal cancer risk in large population studies, something most patients are genuinely surprised to hear when told directly. Oesophageal Cancer with Smoking Combined: Alcohol and tobacco act synergistically on oesophageal tissue and the combined risk is multiplicative not additive, heavy drinkers who smoke sit in a risk category that justifies regular upper endoscopy surveillance rather than waiting for symptoms to show up. Stomach Cancer Through Mucosal Damage: Alcohol directly damages gastric mucosal lining and chronic exposure creates persistent inflammation that increases H. pylori susceptibility and accelerates the gastritis to cancer progression sequence faster than either factor alone. Both together are worse than either alone and risk doesn’t reset quickly after stopping. Read more on AI in GI endoscopy to understand how modern detection tools are changing early cancer surveillance. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has 30 years in gastroenterology, EUS since 1998, trained physicians from 35 countries. Stages GI cancers at Fortis Hospital Mulund with EUS accuracy that CT-dependent workups consistently miss and has seen enough staging errors from outside referrals to know exactly where the gaps are. Patients arrive with a stage. Gets verified here before anyone commits to a treatment plan. That’s the difference between right treatment and expensive wrong treatment. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions What is TNM staging in digestive cancers? TNM describes tumour depth, lymph node involvement, and distant metastasis to classify how far digestive cancer has spread. Is Stage 3 digestive cancer curable? Yes in some cases, Stage 3 cancers with lymph node involvement can still be treated with combined chemotherapy, radiation, and surgery. Why is EUS better than CT for staging GI cancers? EUS images from inside the GI tract giving millimetre-level accuracy for tumour depth and nearby lymph nodes that CT misses regularly. Does staging change during treatment? Yes, restaging after chemotherapy or radiation is standard to assess tumour response before surgery is reconsidered.   Reference links- GI Cancer Staging Guidelines — American College of Gastroenterology Digestive Cancer TNM Staging — World Gastroenterology Organisation

Yes, smoking and alcohol significantly increase the risk of developing digestive cancers, acting independently and combining to magnify the danger. Tobacco is directly linked to oesophageal, stomach, pancreatic, and colorectal cancer while alcohol causes chronic inflammation and tissue damage, raising risk for liver, oesophageal, stomach, and colorectal cancers.  According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “Smoking and alcohol are not just general health risks, they are direct carcinogens for the digestive tract and patients who combine both habits are in a risk category that warrants active surveillance, not just lifestyle advice.” How Does Smoking Increase Digestive Cancer Risk? Tobacco carcinogens don’t stay in the lungs. They travel through the bloodstream, hit the liver, and make contact with digestive tract lining at multiple points along the way. Oesophageal Cancer, Direct Contact: Tobacco smoke and chewing tobacco expose oesophageal lining directly to nitrosamines and risk of squamous cell carcinoma in smokers runs roughly 3 to 5 times higher than non-smokers, climbing further with duration and quantity. Stomach Cancer Gets Worse with H. Pylori: Smoking independently raises stomach cancer risk but also makes existing H. pylori infection more aggressive and harder to eradicate, so a smoker with H. pylori is in a meaningfully worse position than a non-smoker with the same infection. Pancreatic Cancer, Risk Doubles: One of the most consistent findings across studies is that smoking roughly doubles lifetime pancreatic cancer risk and it doesn’t drop back to baseline quickly on quitting, around 10 years of cessation before risk normalises significantly. Colorectal Cancer Builds Over Decades: Risk becomes statistically significant after 30 to 40 pack-years, which means patients who smoked heavily in their 20s and 30s are in a higher colonoscopy surveillance category now even if they stopped years ago. Habit history matters as much as current habits. Specialist in GI cancer treatment factors in cumulative exposure not just what you’re doing today. How Does Diabetes Increase Pancreatic Disease Risk? Alcohol is a Group 1 carcinogen. No safe level for cancer risk has been established and the GI tract takes the most direct hit of any organ system. Liver Cancer Through Cirrhosis: Chronic alcohol use causes cirrhosis and cirrhosis is the strongest single risk factor for hepatocellular carcinoma, cirrhotic patients carry a 1 to 5% annual liver cancer risk regardless of whether they’ve stopped drinking by that point. Colorectal Cancer, Even Moderate Drinking: Risk rises linearly with consumption and even 1 to 2 drinks per day is associated with measurably increased colorectal cancer risk in large population studies, something most patients are genuinely surprised to hear when told directly. Oesophageal Cancer with Smoking Combined: Alcohol and tobacco act synergistically on oesophageal tissue and the combined risk is multiplicative not additive, heavy drinkers who smoke sit in a risk category that justifies regular upper endoscopy surveillance rather than waiting for symptoms to show up. Stomach Cancer Through Mucosal Damage: Alcohol directly damages gastric mucosal lining and chronic exposure creates persistent inflammation that increases H. pylori susceptibility and accelerates the gastritis to cancer progression sequence faster than either factor alone. Both together are worse than either alone and risk doesn’t reset quickly after stopping. Read more on AI in GI endoscopy to understand how modern detection tools are changing early cancer surveillance. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod has 30 years in gastroenterology and EUS since 1998. Trained physicians from 35 countries. Sees smoking and alcohol-related GI cancers regularly at Fortis Hospital Mulund and investigates them properly rather than managing symptoms while the underlying malignancy goes undetected.Patients with decades of combined habits and vague GI symptoms come in regularly. Most leave with a clear picture of what’s actually happening. Better than finding out later when options narrow. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions Which digestive cancer is most strongly linked to smoking? Oesophageal, pancreatic, and stomach cancers have the strongest established links to smoking among digestive cancers. Does quitting smoking reduce digestive cancer risk? Yes, risk decreases progressively after quitting though for pancreatic cancer it takes around 10 years to approach baseline. Is any amount of alcohol safe from a digestive cancer perspective? No safe threshold has been established. Even moderate alcohol consumption is associated with increased colorectal and liver cancer risk. How soon after stopping alcohol does liver cancer risk reduce? Risk reduces gradually but cirrhosis-related liver cancer risk persists even after alcohol cessation in already-cirrhotic patients.   Reference links- Alcohol, Tobacco and GI Cancer Risk — World Gastroenterology Organisation Smoking and Digestive Cancer Evidence — American College of Gastroenterology

Diabetes and pancreatic disease run in both directions. Pancreas produces insulin and damage it through chronic pancreatitis or a tumour and diabetes follows directly. But it works the other way too: long-standing Type 2 diabetes roughly doubles pancreatic cancer risk. New onset diabetes after 50 with no obvious metabolic cause is a recognised early warning of underlying pancreatic pathology. Gets missed constantly. According to Dr. Vipulroy Rathod, an experienced Gastroenterologist in Mumbai, “The diabetes-pancreas connection is one of the most clinically underappreciated relationships in gastroenterology, where patients get managed for blood sugar for months while the underlying pancreatic pathology driving it goes completely uninvestigated.” How Does Pancreatic Disease Cause Diabetes? Pancreas does two jobs. Digestion and blood sugar regulation. Damage one and the other doesn’t escape. Chronic Pancreatitis Destroys Beta Cells: Repeated inflammation progressively wipes out insulin-producing cells and by the time pancreatogenic diabetes shows up the pancreatic damage has been building for years without anyone joining the dots. Tumours Disrupt Insulin Directly: Cancer in the pancreatic head or body interferes with insulin-producing tissue causing sudden glucose dysregulation, and new onset diabetes in a non-obese 55-year-old with no family history is not just an endocrine problem but needs proper pancreatic investigation. Surgery Removes What’s Left: Partial or total pancreatectomy for cancer or severe pancreatitis removes insulin-producing tissue directly, post-surgical diabetes is almost inevitable, and management is completely different from standard Type 2. Cysts Press on Surrounding Tissue: Large cysts impairing both exocrine and endocrine function at once, glucose abnormalities alongside a known cyst, that combination should always prompt reassessment of the cyst itself not just tighter diabetic control. Not one-directional. Specialist in pancreatitis treatment assesses both sides rather than treating blood sugar in isolation. How Does Diabetes Increase Pancreatic Disease Risk? Long-standing diabetes doesn’t just follow pancreatic disease. It actively creates conditions that drive it. Persistent Hyperglycaemia Inflames Pancreatic Tissue: Chronically elevated blood sugar drives low-grade systemic inflammation that damages the pancreas over time, and this is a real mechanism not a theoretical association, which is why long-term Type 2 diabetics carry meaningfully elevated pancreatic cancer risk. High Insulin Levels Feed Abnormal Cells: Insulin resistance means high circulating insulin which acts as a growth signal for abnormal pancreatic cells, and the association across studies is consistent enough to take seriously even where the full mechanism isn’t completely mapped yet. New Onset Diabetes After 50, No Obvious Cause: That presentation needs pancreatic imaging before anyone starts metformin, not after six months of managed blood sugar but before, because this is a recognised early signal of pancreatic malignancy that keeps getting filed away as routine endocrine disease. 10 Plus Years of Poor Control: Risk accumulates and patients with a decade or more of poorly managed diabetes sit in a genuinely different risk category that most are never told about, longer duration and worse control means higher cumulative cellular damage to pancreatic tissue. Managing diabetes without ever checking the pancreas is a gap worth closing. Read more on therapeutic endoscopy to understand what proper investigation looks like. Why Choose Dr. Vipulroy Rathod Dr. Vipulroy Rathod brings 30 years of experience in gastroenterology and has been practising EUS since 1998, with training experience for physicians from 35 countries. At Fortis Hospital Mulund, he regularly manages the overlap between diabetes and pancreatic disease, ensuring both aspects are investigated thoroughly rather than simply referring blood sugar concerns elsewhere. Many patients live with years of managed diabetes without ever having their pancreas properly evaluated, and that diagnostic gap is addressed here. Start Your Treatment Journey Today Book Appointment Call now Frequently Asked Questions Can diabetes be caused by pancreatic disease? Yes, chronic pancreatitis and pancreatic cancer both damage insulin-producing cells and directly cause diabetes. Is new onset diabetes after 50 a sign of pancreatic cancer? It can be. New diabetes without obvious metabolic cause after 50 warrants pancreatic investigation before standalone management. Does treating pancreatic disease improve diabetes control? In some cases yes, particularly when the underlying pancreatic cause is identified and treated early before permanent cell damage occurs. How is pancreatogenic diabetes different from Type 2 diabetes? Pancreatogenic diabetes involves both insulin deficiency and impaired glucagon response, making it harder to manage than standard Type 2. Reference links- Diabetes and Pancreatic Cancer Risk — American College of Gastroenterology Pancreatogenic Diabetes — World Gastroenterology Organisation